Bizotic Commercial board approves preferential issue of up to 1,36,08,000 warrants
Bizotic Commer. · Textiles & Apparels
What the filing says
- Board on 10th September, 2026 approved issuing up to 1,36,08,000 warrants, each convertible into one equity share of face value Rs. 10.00, subject to shareholder and other approvals.
- Allottees are 3 Promoter Group entities and 9 Non-Promoter investors listed in Annexure A(I); the issue price is not stated in the filing.
- Warrants convert within a maximum of 18 months from allotment; 25% of the issue price is payable up-front and 75% on conversion; an EGM will be held.
Why it's rated notable: A preferential issue of up to 1,36,08,000 warrants is a proposal subject to shareholder approval at a future EGM, the filing states no issue price or total rupee amount, and a non-binding event is rated no higher than medium.
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Issue of Securities
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other fundraise / allotment filings this fortnight
- Regency Fincorp reports Q2 & H1 FY27 results with AUM crossing ₹600 crore
- Raymond Realty Limited receives in-principle approval for preferential issue of shares
- OnEMI Technology Solutions allots 2,64,93,882 equity shares via preferential issue
- Natco Pharma allots 1,70,58,082 equity shares in Rights Issue at ₹750 each
- Capital Infra Trust submits post-Institutional Placement unit holding pattern
- Capital Infra Trust raises ₹1,115 crore via QIP for acquiring six HAM road assets
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.